Abstract: Disclosed are an oral film and stick jelly containing glutathione and a milk thistle extract. Provided are an oral disintegrating film, an oral mucosal adhesive film, and a stick jelly that contain glutathione, a milk thistle extract, or the like as an active ingredient, and thus are highly efficacious in improving absorption in the oral mucosa, antioxidant activity, and anti-inflammatory activity, strengthening immunity, and enhancing liver function of humans and companion animals.

Abstract: The present invention relates to a cell reprogramming method using a physical stimulation-mediated environmental influx, and more specifically, by subjecting differentiated or non-differentiated cells to physical stimulation which can promote an environmental influx, such as ultrasonic waves, laser or heat shock, without the introduction of a reprogramming-inducing factor or a chemical substance to the differentiated cells, the cells can be reprogrammed with just the imposition of an external environmental influx into pluripotent cells or arbitrary differentiated cells having a different expression type from the differentiated or non-differentiated cells, and as such an inducement has a simple and effective production process, the possibility of an autogenic cell therapy can be made greater.

Abstract: The present invention relates to a cell reprogramming method using a physical stimulation-mediated environmental influx, and more specifically, by subjecting differentiated or non-differentiated cells to physical stimulation which can promote an environmental influx, such as ultrasonic waves, laser or heat shock, without the introduction of a reprogramming-inducing factor or a chemical substance to the differentiated cells, the cells can be reprogrammed with just the imposition of an external environmental influx into pluripotent cells or arbitrary differentiated cells having a different expression type from the differentiated or non-differentiated cells, and as such an inducement has a simple and effective production process, the possibility of an autogenic cell therapy can be made greater.

Abstract: A method for analyzing the content of boron in a cathode active material is disclosed herein. In some embodiments, a method comprises (S1) introducing boron into a cathode active material to prepare a cathode active material sample, (S2) separating a first liquid layer and a first precipitate by dissolving the sample in water, treating the first liquid layer with acid to form a first resulting solution, and measuring the boron concentration in the first resulting solution by inductively coupled plasma optical emission spectroscopy (ICP-OES), (S3) separating a second liquid layer and a second precipitate by dissolving the first precipitate in water, treating the second liquid layer with acid to form a second resulting solution, and measuring the boron concentration of the second resulting solution by ICP-OES, and (S4) measuring the boron concentration of a third resulting solution, obtained by adding acid and hydrogen peroxide to the second precipitate, by ICP-OES.

Abstract: The present invention relates to a cell reprogramming method using a physical stimulation-mediated environmental influx, and more specifically, by subjecting differentiated or non-differentiated cells to physical stimulation which can promote an environmental influx, such as ultrasonic waves, laser or heat shock, without the introduction of a reprogramming-inducing factor or a chemical substance to the differentiated cells, the cells can be reprogrammed with just the imposition of an external environmental influx into pluripotent cells or arbitrary differentiated cells having a different expression type from the differentiated or non-differentiated cells, and as such an inducement has a simple and effective production process, the possibility of an autogenic cell therapy can be made greater.

Abstract: The present invention relates to a cell reprogramming apparatus using energy capable of promoting an environmental influx, and more particularly, the cell reprogramming apparatus has an effect of inducing reprogramming into new types of pluripotent cells having pluripotent characteristics or arbitrary differentiated cells having a different expression type from the differentiated cells by applying energy such as ultrasonic waves, laser, or heat treatment to the differentiated cells.

Abstract: A method of purifying exhaust gas may include predicting a slip probability of ammonia (NH3) to a rear end of a selective catalytic reduction on diesel particulate filter (SDPF), comparing the predicted ammonia slip probability with a slip probability of ammonia limiting operation of a low pressure-exhaust gas recirculation (LP-EGR) system, comparing an absorption amount of ammonia with a value obtained by multiplying an ammonia absorption target amount by a minimum target absorption amount ratio when the predicted ammonia slip probability is larger than the slip probability of ammonia limiting operation of the LP-EGR system, limiting the operation of the LP-EGR when the absorption amount of ammonia is not larger than the value obtained by multiplying an ammonia absorption target amount by a minimum target absorption amount ratio, and dosing a urea solution.

Abstract: The present invention relates to a jawbone distraction system and control method thereof, including a jawbone extension apparatus, a remote controller and a monitor, the jawbone distractor being configured to allow a horizontal shift of alveolar bone as well as performing vertical jawbone distraction, being precisely controlled in a wireless mode and configured to control a drive of the jawbone distractor through the remote controller while ascertaining a driving state by the monitor.

Abstract: A method of purifying exhaust gas may include predicting a slip probability of ammonia (NH3) to a rear end of a selective catalytic reduction on diesel particulate filter (SDPF), comparing the predicted ammonia slip probability with a slip probability of ammonia limiting operation of a low pressure-exhaust gas recirculation (LP-EGR) system, comparing an absorption amount of ammonia with a value obtained by multiplying an ammonia absorption target amount by a minimum target absorption amount ratio when the predicted ammonia slip probability is larger than the slip probability of ammonia limiting operation of the LP-EGR system, limiting the operation of the LP-EGR when the absorption amount of ammonia is not larger than the value obtained by multiplying an ammonia absorption target amount by a minimum target absorption amount ratio, and dosing a urea solution.

Abstract: Improved G-rich oligonucleotide (GRO) aptamers specific to nucleolin, a method of preparing the aptamers, and a use of the aptamers for diagnosing and/or treating a nucleolin-associated disease, are provided.

Abstract: Improved G-rich oligonucleotide (GRO) aptamers specific to nucleolin, a method of preparing the aptamers, and a use of the aptamers for diagnosing and/or treating a nucleolin-associated disease, are provided.

Abstract: The present invention relates to a jawbone distraction system and control method thereof, including a jawbone extension apparatus, a remote controller and a monitor, the jawbone distractor being configured to allow a horizontal shift of alveolar bone as well as performing vertical jawbone distraction, being precisely controlled in a wireless mode and configured to control a drive of the jawbone distractor through the remote controller while ascertaining a driving state by the monitor.

Abstract: Improved G-rich oligonucleotide (GRO) aptamers specific to nucleolin, a method of preparing the aptamers, and a use of the aptamers for diagnosing and/or treating a nucleolin-associated disease, are provided.

Abstract: Improved G-rich oligonucleotide (GRO) aptamers specific to nucleolin, a method of preparing the aptamers, and a use of the aptamers for diagnosing and/or treating a nucleolin-associated disease, are provided.

Abstract: Provided is a process for purifying a vancomycin wet body, comprising: dissolving a wet body obtained from a microorganism-fermented solution containing vancomycin into a water soluble solvent to a concentration of about 1 to 40 g/L and carrying out reverse osmosis filtration; and carrying out lyophilization of the filtered vancomycin. The process for purifying a vancomycin wet body provides high-purity vancomycin, while avoiding degradation of stability during a drying step.

Abstract: Improved G-rich oligonucleotide (GRO) aptamers specific to nucleolin, a method of preparing the aptamers, and a use of the aptamers for diagnosing and/or treating a nucleolin-associated disease, are provided.

Abstract: The present invention relates to a back light unit for a liquid crystal display device, which can improve safety and reliability of the back light unit; and a method for fabricating the same. The back light unit for a liquid crystal display device includes lamps for supplying a light to a liquid crystal display panel, a printed circuit board of a non-conductive plastic having sockets mounted thereto for supplying a high voltage to the lamps, a cover bottom fastened to the printed circuit board, having the lamps received therein, and a hook shaped projection formed as one unit with the printed circuit board for placing in a hole in the cover bottom for fastening the printed circuit board to the cover bottom.

Abstract: An exhaust-downpipe of a vehicle may include a base portion connected to a top of a catalyst converter having a vertical cylinder, an inlet circularly opened in a horizontal direction, an introduction round portion extending straight along the horizontal direction from the inlet and then and curvedly bent downward toward the base portion, and branch line portions connected to both outsides above the base portion with both ways branching and drawing a circular arc from the introduction round portion.

Abstract: Provided is a process for purifying a vancomycin wet body, comprising: dissolving a wet body obtained from a microorganism-fermented solution containing vancomycin into a water soluble solvent to a concentration of about 1 to 40 g/L and carrying out reverse osmosis filtration; and carrying out lyophilization of the filtered vancomycin. The process for purifying a vancomycin wet body provides high-purity vancomycin, while avoiding degradation of stability during a drying step.